Literature DB >> 27568789

British HIV Association Guidelines on the Use of Vaccines in HIV-Positive Adults 2015.

Anna Maria Geretti1, Gary Brook2, Claire Cameron3, David Chadwick4, Neil French5, Robert Heyderman6, Antonia Ho5, Michael Hunter7, Shamez Ladhani3, Mark Lawton8, Eithne MacMahon9,10, John McSorley2, Anton Pozniak11, Alison Rodger6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27568789     DOI： 10.1111/hiv.12424

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


× No keyword cloud information.
  14 in total

1.  Adjuvanted-influenza vaccination in patients infected with HIV: a systematic review and meta-analysis of immunogenicity and safety.

Authors:  Yong-Chao Chen; Jia-Hao Zhou; Jia-Ming Tian; Bai-Hui Li; Li-Hui Liu; Ke Wei
Journal:  Hum Vaccin Immunother       Date:  2019-11-01       Impact factor: 3.452

Review 2.  Epidemiology and management of healthcare-associated bloodstream infections in non-neutropenic immunosuppressed patients: a review of the literature.

Authors:  Nursel Calik Basaran; Sibel Ascioglu
Journal:  Ther Adv Infect Dis       Date:  2017-10-17

3.  Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study.

Authors:  Kellie L Hawkins; Kirsha S Gordon; Myron J Levin; Adriana Weinberg; Catherine Battaglia; Maria C Rodriguez-Barradas; Sheldon T Brown; David Rimland; Amy Justice; Janet Tate; Kristine M Erlandson
Journal:  J Acquir Immune Defic Syndr       Date:  2018-12-01       Impact factor: 3.731

4.  Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

Authors:  Richard Gilson; Diarmuid Nugent; Kate Bennett; Caroline J Doré; Macey L Murray; Jade Meadows; Lewis J Haddow; Charles Lacey; Frank Sandmann; Mark Jit; Kate Soldan; Michelle Tetlow; Emilia Caverly; Mayura Nathan; Andrew J Copas
Journal:  Health Technol Assess       Date:  2020-09       Impact factor: 4.014

5.  The coverage of influenza and pneumococcal vaccinations among people living with HIV in Denmark: A single-center cross-sectional survey.

Authors:  Lykke Larsen; Mai Thanh Thuy Nguyen; Isik Somuncu Johansen
Journal:  Hum Vaccin Immunother       Date:  2021-03-24       Impact factor: 3.452

6.  Immune response to the hepatitis B vaccine among HIV-infected adults in Uganda.

Authors:  E Seremba; P Ocama; R Ssekitoleko; H Mayanja-Kizza; S V Adams; J Orem; E Katabira; S J Reynolds; R Nabatanzi; C Casper; W Phipps
Journal:  Vaccine       Date:  2021-01-28       Impact factor: 3.641

7.  Human papillomavirus infection: protocol for a randomised controlled trial of imiquimod cream (5%) versus podophyllotoxin cream (0.15%), in combination with quadrivalent human papillomavirus or control vaccination in the treatment and prevention of recurrence of anogenital warts (HIPvac trial).

Authors:  Macey L Murray; Jade Meadows; Caroline J Doré; Andrew J Copas; Lewis J Haddow; Charles Lacey; Mark Jit; Kate Soldan; Kate Bennett; Michelle Tetlow; Mayura Nathan; Richard Gilson
Journal:  BMC Med Res Methodol       Date:  2018-11-06       Impact factor: 4.615

8.  Access to influenza immunisation services by HIV-positive patients in the UK.

Authors:  Elisha Pickett; James Brown; May van Schalkwyk; Alan Hunter; Kelly Edwards; Sarah Edwards; Neal Marshall; Leonie Swaden; Fiona Burns; Margaret Johnson; Marc Lipman
Journal:  Influenza Other Respir Viruses       Date:  2018-03-30       Impact factor: 4.380

Review 9.  HPV vaccination in HIV infection.

Authors:  Charles Jn Lacey
Journal:  Papillomavirus Res       Date:  2019-06-25

10.  No changes on viral load and CD4+ T-cell counts following immunization with 7-valent pneumococcal conjugate vaccine among HIV-infected adults in Malawi.

Authors:  A B Ibarz-Pavon; N French
Journal:  Vaccine       Date:  2018-04-07       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.